TY - JOUR
T1 - Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size
T2 - role of reactive oxygen species
AU - Fantinelli, Juliana C.
AU - Cingolani, Horacio E.
AU - Mosca, Susana M.
N1 - Funding Information:
This work was partly supported by a grant from the Consejo Nacional de Investigaciones Científicas y Técnicas (PIP 2208).
PY - 2006/7
Y1 - 2006/7
N2 - Background: A burst of reactive oxygen species and activation of Na+/H+ exchanger take place at the beginning of reperfusion. The aim of this study was to assess the possible interrelation of the inhibition of Na+/H+ exchanger and reactive oxygen species about the determination of myocardial infarct size. Methods: Isolated rat hearts were submitted to 40 min of coronary occlusion and 2 h of reperfusion. Infarct size was determined through triphenyltetrazolium chloride staining technique and was expressed as a percentage of risk area. Lipid peroxidation, as a marker of oxidative stress, was estimated by the concentration of thiobarbituric reactive substances. Results: Treatment during the first 20 min of reperfusion with a selective inhibitor of Na+/H+ exchanger 1 isoform, HOE 642 (cariporide; 10 μM), significantly diminished infarct size (15.1±2.4% vs. 31±2% in untreated hearts). The administration of a "scavenger" of hydroxyl radical, N-(2-mercaptopropionyl)-glycine (2 mM), decreased infarct size in an extent similar to that of cariporide (18±3%). The combination cariporide+N-(2-mercaptopropionyl)-glycine did not produce additional protection (17±1.7%). Each intervention [HOE 642 or N-(2-mercaptopropionyl)-glycine] and its combination improved the postischemic recovery of myocardial systolic and diastolic functions in a similar extent. The content of the thiobarbituric reactive substances of untreated hearts (1012±144 nmol/g) decreased to 431±81, 390±82, and 433±41 after cariporide, N-(2-mercaptopropionyl)-glycine, and cariporide+N-(2-mercaptopropionyl)-glycine treatments, respectively. Conclusions: The present data support the conclusion that the cardioprotective effect of cariporide is associated with diminution of oxidative stress.
AB - Background: A burst of reactive oxygen species and activation of Na+/H+ exchanger take place at the beginning of reperfusion. The aim of this study was to assess the possible interrelation of the inhibition of Na+/H+ exchanger and reactive oxygen species about the determination of myocardial infarct size. Methods: Isolated rat hearts were submitted to 40 min of coronary occlusion and 2 h of reperfusion. Infarct size was determined through triphenyltetrazolium chloride staining technique and was expressed as a percentage of risk area. Lipid peroxidation, as a marker of oxidative stress, was estimated by the concentration of thiobarbituric reactive substances. Results: Treatment during the first 20 min of reperfusion with a selective inhibitor of Na+/H+ exchanger 1 isoform, HOE 642 (cariporide; 10 μM), significantly diminished infarct size (15.1±2.4% vs. 31±2% in untreated hearts). The administration of a "scavenger" of hydroxyl radical, N-(2-mercaptopropionyl)-glycine (2 mM), decreased infarct size in an extent similar to that of cariporide (18±3%). The combination cariporide+N-(2-mercaptopropionyl)-glycine did not produce additional protection (17±1.7%). Each intervention [HOE 642 or N-(2-mercaptopropionyl)-glycine] and its combination improved the postischemic recovery of myocardial systolic and diastolic functions in a similar extent. The content of the thiobarbituric reactive substances of untreated hearts (1012±144 nmol/g) decreased to 431±81, 390±82, and 433±41 after cariporide, N-(2-mercaptopropionyl)-glycine, and cariporide+N-(2-mercaptopropionyl)-glycine treatments, respectively. Conclusions: The present data support the conclusion that the cardioprotective effect of cariporide is associated with diminution of oxidative stress.
KW - Cariporide
KW - Ischemia-reperfusion injury
KW - MPG
KW - NHE
KW - ROS
UR - http://www.scopus.com/inward/record.url?scp=33745810610&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745810610&partnerID=8YFLogxK
U2 - 10.1016/j.carpath.2006.04.005
DO - 10.1016/j.carpath.2006.04.005
M3 - Article
C2 - 16844548
AN - SCOPUS:33745810610
SN - 1054-8807
VL - 15
SP - 179
EP - 184
JO - Cardiovascular Pathology
JF - Cardiovascular Pathology
IS - 4
ER -